0001477932-23-000262.txt : 20230113
0001477932-23-000262.hdr.sgml : 20230113
20230113160120
ACCESSION NUMBER: 0001477932-23-000262
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230112
FILED AS OF DATE: 20230113
DATE AS OF CHANGE: 20230113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reynolds Cameron John
CENTRAL INDEX KEY: 0001340610
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36833
FILM NUMBER: 23528681
MAIL ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VOLITIONRX LTD
CENTRAL INDEX KEY: 0000093314
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 911949078
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
BUSINESS PHONE: 1 (646) 650-1351
MAIL ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
FORMER COMPANY:
FORMER CONFORMED NAME: STANDARD CAPITAL CORP
DATE OF NAME CHANGE: 19990812
4
1
form4.xml
FORM 4
X0306
4
2023-01-12-05:00
false
0000093314
VOLITIONRX LTD
VNRX
0001340610
Reynolds Cameron John
1489 WEST WARM SPRINGS ROAD
SUITE 110
HENDERSON
NV
89014
true
true
false
false
President and CEO
Common Stock
2023-01-12-05:00
4
A
false
33375
0.00
A
1444468
D
Common Stock
1007718
I
By Concord International, Inc.
Common Stock
34076
I
By Spouse
On October 4, 2022, the reporting person was awarded 89,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 33,375 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 11,125 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 15,575 restricted stock units subject to the award previously vested and remain subject to time-based vesting.
The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.
/s/ Cameron John Reynolds
2023-01-13-05:00